| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 83970 |
|
34,484 |
32,147 |
$747K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
41,342 |
37,708 |
$679K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,987 |
3,990 |
$602K |
| 82607 |
|
58,722 |
53,855 |
$471K |
| 84443 |
Thyroid stimulating hormone (TSH) |
54,131 |
49,010 |
$452K |
| 84134 |
|
58,888 |
54,396 |
$433K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15,286 |
14,287 |
$431K |
| 80053 |
Comprehensive metabolic panel |
78,915 |
72,367 |
$423K |
| 82746 |
|
51,505 |
47,111 |
$396K |
| 83880 |
|
19,665 |
18,183 |
$375K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
62,437 |
58,417 |
$353K |
| 83721 |
|
54,692 |
50,536 |
$309K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
74,853 |
68,229 |
$295K |
| 83718 |
|
52,298 |
48,266 |
$238K |
| 80050 |
General health panel |
11,898 |
11,353 |
$205K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
77,049 |
66,353 |
$146K |
| 83735 |
|
34,444 |
32,118 |
$116K |
| 84439 |
|
23,135 |
21,308 |
$108K |
| 36415 |
Collection of venous blood by venipuncture |
72,566 |
64,270 |
$90K |
| 87482 |
|
4,177 |
3,637 |
$90K |
| 84550 |
|
31,387 |
29,295 |
$77K |
| 83090 |
|
8,324 |
7,388 |
$77K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,055 |
2,793 |
$72K |
| 82274 |
|
5,021 |
4,968 |
$71K |
| 87640 |
|
4,690 |
4,098 |
$68K |
| 87653 |
|
4,707 |
4,113 |
$68K |
| 84481 |
|
6,867 |
6,118 |
$56K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
5,024 |
4,675 |
$53K |
| 82728 |
|
8,194 |
7,399 |
$52K |
| 84100 |
|
19,103 |
17,683 |
$46K |
| 82043 |
|
10,111 |
9,575 |
$36K |
| 83550 |
|
7,903 |
7,127 |
$32K |
| 80074 |
|
973 |
894 |
$29K |
| 83540 |
|
9,038 |
8,166 |
$29K |
| 84153 |
|
2,605 |
2,413 |
$29K |
| 80061 |
Lipid panel |
3,809 |
3,504 |
$25K |
| 82570 |
|
8,024 |
7,579 |
$24K |
| 80164 |
|
2,722 |
2,514 |
$22K |
| 86800 |
|
2,996 |
2,733 |
$22K |
| 86376 |
|
3,038 |
2,768 |
$20K |
| 86430 |
|
4,656 |
4,331 |
$18K |
| 82248 |
|
6,218 |
5,618 |
$18K |
| 81001 |
|
10,136 |
9,102 |
$17K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
916 |
837 |
$16K |
| 86140 |
|
4,234 |
4,037 |
$14K |
| 87186 |
|
3,665 |
3,182 |
$14K |
| 86803 |
|
1,858 |
1,751 |
$14K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
364 |
362 |
$13K |
| 80377 |
|
3,657 |
3,519 |
$12K |
| 80177 |
|
1,625 |
1,464 |
$11K |
| 82523 |
|
1,026 |
988 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
244 |
213 |
$9K |
| 85610 |
|
2,533 |
2,077 |
$5K |
| 87481 |
|
448 |
415 |
$5K |
| 80171 |
|
379 |
328 |
$5K |
| 82977 |
|
495 |
483 |
$3K |
| 85027 |
|
1,065 |
1,007 |
$3K |
| 82465 |
|
1,515 |
1,383 |
$3K |
| 82172 |
|
337 |
123 |
$3K |
| 83690 |
|
793 |
670 |
$2K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
1,932 |
1,766 |
$2K |
| 82150 |
|
738 |
621 |
$2K |
| 82550 |
|
454 |
421 |
$2K |
| 80156 |
|
191 |
178 |
$2K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
1,073 |
1,034 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
370 |
337 |
$1K |
| 81003 |
|
1,115 |
1,048 |
$1K |
| 86141 |
|
165 |
154 |
$1K |
| 80185 |
|
162 |
154 |
$1K |
| 80376 |
|
272 |
262 |
$1K |
| 80178 |
|
227 |
216 |
$1K |
| 84152 |
|
84 |
80 |
$898.03 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
175 |
167 |
$710.11 |
| 84478 |
|
143 |
129 |
$670.96 |
| 81002 |
|
175 |
171 |
$317.90 |
| 84156 |
|
94 |
90 |
$245.46 |
| 85730 |
|
112 |
90 |
$238.12 |
| 87088 |
|
58 |
54 |
$190.90 |
| 86703 |
|
16 |
12 |
$137.06 |
| 80175 |
|
12 |
12 |
$125.71 |
| 87340 |
|
22 |
16 |
$112.03 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
133 |
119 |
$100.00 |
| 85045 |
|
42 |
41 |
$78.06 |
| 82565 |
|
29 |
28 |
$67.58 |
| 85651 |
|
21 |
21 |
$46.63 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
34 |
32 |
$0.00 |